Biopharma industry in the US is rooted in a strong R&D sector, with the employment percentage being three times larger than the industry average, suggests PhRMA. The pursuit of biologic treatments and the development of these over the different clinical stages has formed a strong industry sector in the US, pivotal for the country’s economy, a recently published report by the Pharmaceutical Research and Manufacturers of America (PhRMA) and TEConomy Partners suggests. Click Here For Complete Article Text
|
||||||||||||||||||
| Application Sequencing | ||||||||||||||||||
|
||||||||||||||||||
| Company | Product | Process | Other Subjects | Event | Event Date | Location | Publication | Publication Date | Text Descriptor | |||||||||
|
|
|
|
|
|
|
|
|
|||||||||||